Dr. Rappard presented the results at the Society of Neurointerventional Surgery annual meeting on behalf of Walter Bini, MD, a physician from Germany. ISS is a minimally invasive treatment device designed to relieve the chronic pain connected with lumbar spinal stenosis and is an alternative to surgery. ISS is implanted between the spinous processes through a small incision and then supports the spinal column to open passageways containing the spinal cord and nerves.
During the clinical research, ISS was implanted in 121 patients whose pain failed to subside after employing other treatment options. After one year, patients experienced 64 percent improvement in back functions, 49 percent improvements in back pain and 53 percent improvement in leg pain.
Read the Los Angeles Brain and Spine Institute release on the Superion Interspinous Spacer clinical results.
Read more coverage on lumbar spine stenosis:
– MiDAS I Study Finds Significant Improvement in Lumbar Spinal Stenosis Patients Undergoing Mild Procedure
– VertiFlex Announces 100th Patient Enrolled in Superion IDE Trial
– Spine Surgeon First in Pennsylvania to Implant Device to Treat Leg Pain Caused by Spinal Stenosis
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
